Concurrent Investment Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
3,197
+404
+14% +$171K 0.01% 907
2026
Q1
$1.32M Sell
2,793
-158
-5% -$79.5K 0.01% 766
2025
Q4
$1.38M Buy
2,951
+665
+29% +$309K 0.02% 702
2025
Q3
$974K Buy
2,286
+51
+2% +$19.8K 0.02% 665
2025
Q2
$856K Buy
2,235
+93
+4% +$33.5K 0.02% 649
2025
Q1
$740K Buy
2,142
+106
+5% +$34.1K 0.02% 627
2024
Q4
$611K Sell
2,036
-667
-25% -$233K 0.02% 622
2024
Q3
$1.1M Buy
2,703
+561
+26% +$205K 0.03% 433
2024
Q2
$688K Buy
2,142
+42
+2% +$13.6K 0.02% 517
2024
Q1
$700K Buy
2,100
+152
+8% +$46.4K 0.03% 460
2023
Q4
$527K Buy
+1,948
New +$481K 0.02% 484

Other funds holding HCA

Concurrent Investment Advisors's HCA Position: Q2 2026 in Review

Concurrent Investment Advisors increased its HCA Healthcare (HCA) stake by 14% in Q2 2026, buying an estimated $171K and bringing the position to 3,197 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #907.

Concurrent Investment Advisors first reported a position in HCA in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.38M in Q4 2025. 379 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Concurrent Investment Advisors held 3,197 shares of HCA Healthcare worth $1.25M as of Q2 2026.
  • Concurrent Investment Advisors bought 404 HCA Healthcare shares in Q2 2026, an estimated $171K.
  • HCA Healthcare made up 0.01% of Concurrent Investment Advisors's portfolio in Q2 2026, its #907 holding.
  • Concurrent Investment Advisors first reported a position in HCA Healthcare in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's HCA Healthcare position peaked at $1.38M in Q4 2025.
  • 379 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.